Heart Failure Management for Patient With CIED Remotely Monitored
Prospective Real World Heart Failure Management for Patient With CIED Remotely Monitored
Implicity
1,132 participants
Dec 19, 2025
INTERVENTIONAL
Conditions
Summary
This randomized, controlled, open-label, parallel, multicenter clinical study evaluates the efficacy of SmartSignalHF compared with heart failure (HF) remote monitoring (RM) standard of care in implanted patients with heart failure. The primary objective is to determine whether SmartSignalHF reduces all-cause mortality and HF hospitalizations at 12 months.
Eligibility
Inclusion Criteria9
- Patient aged 18-85
- Patient diagnosed with a New York Heart Association (NYHA) class II or III
- Patients with left ventricular ejection fraction ≼ 40 %
- Patient implanted with an ICD or CRT-D (BiV and/or LBBA pacing) since at least 30 days and compatible with SignalHF (Biotronik, Boston Scientific and Medtronic)
- Non-activation of others HF multisensor algorithms
- Patient remote monitored on Implicity CIED platform
- Patient with a documented diagnosis of heart failure, eligible to reimbursement in France or Germany for HF remote monitoring
- Patient is willing to be remotely monitored for heart failure
- HF treated according to European Society of Cardiology (ESC) guidelines
Exclusion Criteria7
- Patients undergoing or awaiting heart transplant or left ventricular assist device (LVAD) procedures
- Patients with a life expectancy of less than 12 months
- Patients enrolled in concurrent clinical studies
- Patients with a history of non-compliance with medical care or inability to comply with the study protocol
- Patients already receiving remote monitoring for heart failure
- Pregnant or breastfeeding women
- Subjects under legal protection
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
SmartSignalHF; a solution aiming to predict episodes of cardiac decompensation in patients implanted with an ICD or CRT-D
HF RM standard of care defined in the country (France or Germany)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07247032